NRIXNurix Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Nurix Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIXEsta | $2.6B#8 | — | 6.5x#9 | 31.4x#4 | 54.0%#4 | -36.6%#8 | -340.2%#4 | -65.7%#11 | — | — | — | — |
| VKTX | $3.4B#1 | — | 8.3x#12 | — | — | -227.1%#15 | — | -88.1%#14 | — | — | — | — |
| RCUS | $3.3B#2 | — | 7.0x#10 | 99.0x#6 | -35.3%#8 | -24.7%#6 | -1169.7%#7 | -76.1%#13 | -93.0%#10 | — | — | — |
| DYN | $3.2B#3 | — | 4.6x#6 | — | — | -40.6%#10 | — | -0.0%#2 | -1301.5%#11 | — | — | — |
| ARQT | $3.2B#4 | 115.1x#2 | 14.4x#13 | 8.5x#3 | 91.3%#3 | 88.5%#1 | -3.3%#2 | -7.3%#4 | -4.1%#2 | — | — | — |
| MBX | $3.0B#5 | — | 7.3x#11 | — | — | -40.5%#9 | — | -21.2%#6 | — | — | — | — |
| IMNM | $2.8B#7 | — | 5.3x#7 | 400.1x#8 | -23.2%#7 | 27.5%#2 | -3228.8%#8 | -40.4%#9 | -72.8%#8 | — | 160.1%#1 | — |
| PGEN | $2.8B#6 | — | 63.8x#15 | 287.1x#7 | 146.7%#2 | -98.6%#13 | -1141.1%#6 | -575.1%#15 | -91.2%#9 | — | — | — |
| IRON | $2.6B#9 | — | 4.1x#4 | — | — | -94.0%#11 | — | -32.9%#8 | -39.0%#4 | — | — | — |
| MLYS | $2.5B#10 | — | 4.5x#5 | — | — | 13.0%#3 | — | -28.1%#7 | -41.3%#5 | — | — | — |
| VERA | $2.5B#12 | — | 6.0x#8 | — | — | -96.9%#12 | — | -73.5%#12 | -72.7%#7 | — | — | — |
| SUPN | $2.5B#11 | — | 2.4x#1 | 3.4x#2 | 8.6%#6 | -152.2%#14 | -8.7%#3 | -3.7%#3 | -5.0%#3 | — | — | — |
| VRDN | $2.5B#13 | — | 3.7x#3 | 34.7x#5 | 23359.9%#1 | -26.9%#7 | -512.9%#5 | -51.7%#10 | -54.5%#6 | — | — | — |
| HRMY | $2.5B#14 | 13.6x#1 | 2.5x#2 | 2.8x#1 | 21.5%#5 | 9.1%#5 | 24.0%#1 | 15.9%#1 | 25.5%#1 | 4#1 | — | — |
| SLS | $2.3B#15 | — | 16.5x#14 | — | -100.0%#9 | 13.0%#4 | — | -19.5%#5 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-21.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice